Moderate coffee intake—3-4 cups daily—slows telomere shortening in severe mental disorder patients, equating to 5 extra biological years, per a November 25, 2025, BMJ Mental Health study of 436 Norwegian adults with schizophrenia, bipolar, or psychosis-linked depression. King’s College London researchers found non-drinkers’ telomeres—cellular aging caps—shorter than 3-4 cup cohorts’, whose lengths mirrored 5 years younger peers after adjusting for age, sex, ethnicity, smoking, and meds; 5+ cups showed no benefit, potentially accelerating attrition.
Telomeres—DNA end-caps eroding with replication—shorten faster in mental illness, slashing 15-year life expectancy via oxidative stress; coffee’s polyphenols/antioxidants curb this, per the inverted J-curve: optimal 3-4 cups (300-400mg caffeine) yield longest telomeres, aligning NHS/FDA max. Vid Mlakar: “Coffee’s dose-response mirrors general population benefits—oxidative shield slows inflammaging.” NHANES 1999-2002’s 5,826 adults linked caffeine/coffee to longer telomeres (0.12-year equivalent per cup), while Nurses’ Health Study’s 4,780 women affirmed positives; instant coffee’s inverse (0.38-year loss per cup) highlights brewing’s role.
UK Biobank’s 5,000+ cohort ties green tea/coffee to LTL preservation, soft drinks to acceleration; mental health‘s 15-year gap narrows via lifestyle levers like 3-4 cups’ 5-year boon. Limitations: observational causality, confounders like tobacco; yet, 90%+ accuracy in biomarkers signals scalability. Coffee’s telomere tonic—3-4 cups’ cellular shield—slows aging’s scourge, where brews bolster biology in brain’s battleground.
